Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy surrounding the project, the company was building valuable technologies that justify its $10.2 billion valuation. Now, roughly 16 months later, the startup is in talks to raise new funding at a $20 billion to $30 billion valuation, Axios reported. It’s not clear who is leading the new round, or how much capital the five-year-old company is looking to raise.
- ▪When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy surrounding the project, the company was
- ▪Now, roughly 16 months later, the startup is in talks to raise new funding at a $20 billion to $30 billion valuation, Axios reported.
- ▪It’s not clear who is leading the new round, or how much capital the five-year-old company is looking to raise.
Opening excerpt (first ~120 words) tap to expand
When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy surrounding the project, the company was building valuable technologies that justify its $10.2 billion valuation. Now, roughly 16 months later, the startup is in talks to raise new funding at a $20 billion to $30 billion valuation, Axios reported. It’s not clear who is leading the new round, or how much capital the five-year-old company is looking to raise. But we do know, according to the report, that Colossal has started generating revenue over the last year. Colossal co-founder and CEO Ben Lamm told TechCrunch last year that the company sees three revenue streams for the business.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at TechCrunch.
Discussion
0 commentsMore from TechCrunch
